{
  "meta": {
    "title": "Critical_Care_And_Medical_Oncology",
    "url": "https://brainandscalpel.vercel.app/critical-care-and-medical-oncology-2bd32fb8.html",
    "scrapedAt": "2025-11-30T11:12:49.854Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">APACHE II</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">SOFA</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">MoCA</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">SAPS III</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a scoring system used to assess the severity of illness in the ICU?</span></p>",
      "unique_key": "DT1196597",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196597,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>MoCA - Montreal Cognitive Assessment tool is used to assess cognitive function in patients with dementia. Others are scoring systems used in the ICU.<strong></strong></p>\r\n<p><strong>MoCA:</strong></p>\r\n<p><strong>The test covers:</strong></p>\r\n<ul>\r\n<li>Attention and concentration</li>\r\n<li>Executive functions</li>\r\n<li>Memory</li>\r\n<li>Language</li>\r\n<li>Visuospatial skills</li>\r\n<li>Abstract thinking</li>\r\n<li>Calculations</li>\r\n<li>Orientation to time and place</li>\r\n</ul>\r\n<p><strong>Interpretation:</strong></p>\r\n<ul>\r\n<li>Score: Total out of 30 points</li>\r\n<li>A score of 26 or above is generally considered normal</li>\r\n<li>Lower scores may indicate cognitive impairment<strong></strong></li>\r\n</ul>\r\n<p><strong>SOI scores:</strong></p>\r\n<p>In the ICU, illnesses are frequently categorised by degree of severity. Numerous severity-of-illness (SOI) scoring systems have been developed for this. The most commonly utilised scoring systems are:</p>\r\n<ul>\r\n<li>SOFA (Sequential Organ Failure Assessment)<strong>(Option B)</strong></li>\r\n<li>APACHE (Acute Physiology and Chronic Health Evaluation)<strong>(Option A)</strong></li>\r\n<li>SAPS (Simplified Acute Physiology Score) systems. <strong>(Option D)</strong></li>\r\n</ul>",
      "correct_choice_id": 3,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Altered mental system</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory rate >35/min</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">SBP <90mm Hg</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">None</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not part of the qSOFA scoring system for sepsis?</span></p>",
      "unique_key": "DT1196603",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196603,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Respiratory rate of more than 22/min is a criterion, and not more than 35/min.</li>\r\n<li>SOFA stands for sequential organ failure assessment. It's a tool used to assess the risk of sepsis and related mortality.</li>\r\n<li>qSOFA is a quick assessment tool used for the identification of patients at risk of sepsis-related mortality, especially outside ICUs.</li>\r\n<li>Patients with suspected infection can be predicted to have poor outcomes typical of sepsis if they have at least two of the clinical criteria of the score.<strong></strong></li>\r\n</ul>\r\n<p><strong>qSOFA clinical criteria:</strong></p>\r\n<ul>\r\n<li>Respiratory rate &gt; 22</li>\r\n<li>Altered mental status<strong>(Option A)</strong></li>\r\n<li>Systolic blood pressure &lt; 90mmHg<strong>(Option C)</strong></li>\r\n<li>qSOFA is intended to screen patients for ICU admission from out-of-hospital, emergency department, and hospital ward settings.<strong></strong></li>\r\n</ul>\r\n<p><strong>Key takeaways:</strong></p>\r\n<p><strong>SEPSIS III criteria:</strong></p>\r\n<p><strong>Sepsis: </strong>Sepsis is defined by SEPSIS-3 criteria as suspected or documented infection and an acute increase in &gt;2 sepsis-related organ failure assessment&nbsp;(SOFA) points.</p>\r\n<p><strong>Septic shock: </strong>Documented or suspected infection + Need for vasopressors to maintain<strong> </strong>MAP more than or equal to 65mmHg and elevated lactate (&gt;2 mmol/L) defines the septic shock according to SEPSIS-33 criteria</p>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyponatremia</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertriglyceridemia</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoproteinemia</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoglycemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\"> A 55-year-old male, known case of CKD on peritoneal dialysis, was admitted to the hospital with non-specific symptoms of generalised weakness and malaise. Routine blood investigations were sent. Which of the following is not a common complication of Peritoneal Dialysis?</span></p>",
      "unique_key": "DT1196613",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196613,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Hypoglycemia is not a common complication of peritoneal dialysis.<strong>&nbsp;</strong></p>\r\n<p><strong>Peritoneal dialysis is associated with a variety of metabolic complications:</strong></p>\r\n<ul>\r\n<li>Albumin and other proteins can be lost across the peritoneal membrane in concert with the loss of metabolic wastes. <strong>(Option C)</strong></li>\r\n<li>Hyponatremia occurs in about 6-29% of PD patients. It may result from excessive free water intake, use of icodextrin, hyperglycemia-related osmotic shifts, or failure to remove free water effectively. <strong>(Option A)</strong></li>\r\n<li>Hyperglycemia and weight gain are also common complications of peritoneal dialysis.</li>\r\n<li>Several hundred calories in the form of dextrose are absorbed each day, depending on the concentration of dextrose employed.</li>\r\n<li>Patients receiving peritoneal dialysis, particularly those with diabetes mellitus, are prone to other complications of insulin resistance, including hypertriglyceridemia. <strong>(Option B)</strong></li>\r\n</ul>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">COPD with acute exacerbation</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute hypoxemic respiratory failure</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute pulmonary oedema</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Obstructive sleep apnea syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not an indication of Non-Invasive Ventilation?</span></p>",
      "unique_key": "DT1196620",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196620,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>It has been observed that patient intolerance is the major limitation in the widespread application of non-invasive ventilation because it can result in both physical and psychological discomfort.</p>\r\n<ul>\r\n<li>In addition, NIV has had limited success in patients with acute hypoxemic respiratory failure, for whom endotracheal intubation and conventional MV remain the ventilatory method of choice.</li>\r\n<li>Guidelines suggest high-flow nasal cannula (HFNC) rather than NIV in most such cases unless very mild and early, under close supervision.<strong></strong></li>\r\n</ul>\r\n<p><strong>The most common reasons for instituting MV are:</strong></p>\r\n<ul>\r\n<li><strong>Acute respiratory failure with hypoxemia, which accounts for ~65% of all ventilated cases: </strong>\r\n<ul>\r\n<li>Acute respiratory distress syndrome</li>\r\n<li>Heart failure with pulmonary oedema</li>\r\n<li>Pneumonia</li>\r\n<li>Sepsis</li>\r\n<li>Complications of surgery and trauma</li>\r\n</ul>\r\n</li>\r\n<li><strong>Hypercarbic ventilatory failure :</strong>\r\n<ul>\r\n<li>Due to coma (15%)</li>\r\n<li>Exacerbations of chronic obstructive pulmonary disease (COPD; 13%)</li>\r\n<li>Neuromuscular diseases (5%)</li>\r\n</ul>\r\n</li>\r\n</ul>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypernatremia</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyponatremia</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">No change in Na</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Relative sodium deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old female who is a known case of type 2 diabetes mellitus was admitted with complaints of excessive thirst and frequent urination. Laboratory investigations showed blood sugar was 700 mg/dl and serum sodium of 115 meq. Insulin infusion was started. Which of the following events will occur after insulin administration?</span></p>",
      "unique_key": "DT1196628",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196628,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>In hyperosmolar coma noted with diabetes mellitus, serum sodium concentration is often decreased due to the osmotic flux of water from the intracellular to the extracellular space in the presence of hyperglycemia.</p>\r\n<ul>\r\n<li>Once insulin lowers the glucose level, water moves back into cells, concentrating sodium in the extracellular fluid.</li>\r\n<li>This increases the serum sodium toward its true value.</li>\r\n<li>Despite low measured sodium due to dilution, the total body sodium is deficient (due to osmotic diuresis and losses).</li>\r\n<li>After insulin and correction, sodium levels normalise, but the underlying relative sodium deficit persists and must be addressed. <strong>(Other options ruled out)</strong></li>\r\n<li>Therefore, sodium and blood sugar follow an inverse relationship in DM.<strong></strong></li>\r\n</ul>\r\n<p><strong>Diagnostic criteria for HHS:</strong></p>\r\n<ul>\r\n<li>Profound dehydration</li>\r\n<li>Neuronal symptoms</li>\r\n<li>Plasma sugar level&gt;600 mg/dl</li>\r\n<li>Normal anion gap &lt;14mEq/L</li>\r\n<li>Arterial pH &gt;7.3</li>\r\n<li>Plasma bicarbonate levels &gt;15 mmol/L</li>\r\n<li>Absence of ketones</li>\r\n</ul>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Sweating</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Palpitation</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Hunger</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Paresthesias</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a cholinergic symptom of hypoglycemia?</span></p>",
      "unique_key": "DT1196635",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196635,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Cholinergic symptoms of hypoglycemia, mediated by acetylcholine, which is released from sympathetic postganglionic neurons, are sweating, hunger and paresthesia.</li>\r\n<li>Adrenergic symptoms mediated by norepinephrine, which is released from sympathetic postganglionic neurons and epinephrine released from the adrenal medulla, are the tremor, anxiety, and palpitations.</li>\r\n</ul>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">60mEq</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">80mEq</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">100mEq</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">140 mEq</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient who is on Amphotericin B developed weakness and cramps. The serum potassium was 2.3 mEq/dl. Calculate the total parenteral potassium supplementation to be prescribed to the patient over the next 24 hours.</span></p>",
      "unique_key": "DT1196639",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196639,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>For causing a rise of potassium in blood by 1mEq/dl,200 mEq of potassium supplementation is needed.</p>\r\n<ul>\r\n<li>Since symptoms develop with serum potassium less than 3mEq/dl, the clinician should provide sufficient potassium to rise to 3mEq/dl through the IV route.</li>\r\n<li>Therefore, mathematically speaking, this patient needs approximately 0.7 mEq/dl of potassium to rise in the blood, resulting in a requirement of 0.7 x 200 = 140 mEq over 24 hours.<strong></strong></li>\r\n</ul>\r\n<p><strong>Management of Hypokalemia:</strong></p>\r\n<ul>\r\n<li>Oral KCl is preferred for mild to moderate hypokalemia.</li>\r\n<li>Severe Hypokalemia (&lt;2.5 mEq/L) requires intravenous potassium, typically at a rate of 10-20 mEq/hr (up to 40 mEq/hr centrally with ECG monitoring)</li>\r\n<li>The maximum total daily KCl dose in adults is typically 100 mEq/day, to avoid the risk of overcorrection and cardiac complications.</li>\r\n<li>Individualise dosing in CKD or renal impairment with careful monitoring.</li>\r\n<li>Magnesium correction is mandatory before or during K supplementation.<strong></strong></li>\r\n</ul>\r\n<p><strong>Clinical features of Hypokalemia:</strong></p>\r\n<ul>\r\n<li>Most patients with mild hypokalemia may have no symptoms.</li>\r\n<li>Moderate to severe hypokalemia (&lt;3.0 mEq/L) causes muscle, cardiac, and GI dysfunction and can be life-threatening.</li>\r\n<li>ECG changes often precede clinical symptoms, making ECG monitoring essential in moderate/severe cases.</li>\r\n<li>Hypokalemia raises the risk of arrhythmias, especially in those with existing cardiac disease or on digitalis therapy.</li>\r\n<li>Death in hypokalemia occurs commonly due to respiratory failure.<strong></strong></li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Bilateral asterixis typically arises from metabolic causes such as hepatic encephalopathy, uremic encephalopathy, CO₂ retention, or drug intoxication-not localised brain injury or infection.</li>\r\n<li>It is elicited by asking the patient to extend arms, dorsiflex wrists, and watching for the characteristic flapping motion.</li>\r\n</ul>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Albumin</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Colloids</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood transfusion</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate laparoscopy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old patient with abdominal trauma presents with Hypovolemic shock and is not responsive to crystalloids. Which of the following is the next line of management?</span></p>",
      "unique_key": "DT1196666",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196666,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>In a trauma patient presenting with hypovolemic shock unresponsive to crystalloids, especially in the context of abdominal trauma, the appropriate next step is Blood transfusion.<strong>&nbsp;</strong></p>\r\n<p><strong>Management of Hypovolemic shock due to haemorrhage:</strong></p>\r\n<ul>\r\n<li>When hypovolemic shock is due to haemorrhage from trauma, the priority is to restore intravascular volume and oxygen-carrying capacity using blood products, particularly packed red blood cells (PRBCs).</li>\r\n<li>While crystalloids are acceptable initially if blood is not immediately available, continuing crystalloids alone is insufficient and potentially harmful, leading to dilutional coagulopathy, hypothermia, and worsening acidosis.</li>\r\n<li>Colloids and albumin have not demonstrated survival benefit over crystalloids and are generally not recommended in hemorrhagic trauma resuscitation.<strong> (Option A and B ruled out).</strong></li>\r\n<li>Hyperoncotic starches are specifically discouraged due to risks of acute kidney injury and coagulopathy.</li>\r\n<li>Guidelines support early activation of massive transfusion protocols, including balanced transfusion of PRBCs, plasma, and platelets (often 1:1:1 ratio) when indications like persistent instability after initial resuscitation are present.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d19tx39t2q3u48.cloudfront.net/NEETPGMCQ/65348ccd-73f6-4669-b1ca-0f0830cc947d.png\">",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Noradrenaline</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenaline</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Vasopressin</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Dopamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the vasopressor of choice in patients with septic shock?</span></p>",
      "unique_key": "DT1196673",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196673,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>In patients with distributive shock, the primary action used to mitigate the shock is to increase the systemic vascular resistance.</li>\r\n<li>Norepinephrine is the first-choice vasopressor. It has potent action at alpha1 and beta1 adrenergic receptors.</li>\r\n<li>The alpha1 causes vasoconstriction while beta1 has positive inotropic and chronotropic effects. These contribute to an increase in MAP.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Adrenaline(Option B):</strong> At high doses, epinephrine has a similar profile (at lower doses the &beta; effects predominate), but is associated with tachyarrhythmia, myocardial ischemia, decreased splanchnic blood flow, pulmonary hypertension, and acidosis.</p>\r\n<p><strong>Vasopressin(Option C): </strong>Vasopressin is safe and has a role as a&nbsp;second agent for hypotension in septic shock.</p>\r\n<p><strong>Dopamine(Option D):</strong> Dopamine does not have a role as a first-line agent in distributive shock.</p>",
      "correct_choice_id": 81,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Osmolar gap >10 mOsm/kg</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Osmolar gap >20mOsm/kg</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">pH > 7.40</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">pH > 7.50</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old male patient with ethylene glycol intoxication was referred to a tertiary care centre for further management. Which of the following is an indication for hemodialysis in such a case?</span></p>",
      "unique_key": "DT1196684",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196684,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The combination of a high AG and high osmolar gap in a patient is highly suspicious of Ethylene glycol toxicity.</p>\r\n<ul>\r\n<li>Hemodialysis is indicated in these patients if the osmolar gap exceeds 20 mOsm/kg or the arterial pH is &lt;7.3.</li>\r\n<li>Ingestion of EG (commonly used in antifreeze) leads to a metabolic acidosis and severe damage to the CNS, heart, lungs, and kidneys.</li>\r\n<li>Diagnosis is further enabled by recognition of oxalate crystals in the urine.<strong></strong></li>\r\n</ul>\r\n<p><strong>Ethylene Glycol poisoning:</strong></p>\r\n<ul>\r\n<li>Ethylene glycol itself is relatively non-toxic, but its metabolites, glycolic acid, glyoxylic acid, and oxalic acid, cause severe metabolic derangements and organ injury.</li>\r\n<li>These metabolites lead to high anion gap metabolic acidosis, renal damage via calcium oxalate deposition, and hypocalcemia.<strong></strong></li>\r\n</ul>\r\n<p><strong>Clinical features:</strong></p>\r\n<p><strong>Early Phase (30 min-12 hr):</strong></p>\r\n<ul>\r\n<li>Presents like ethanol intoxication: confusion, ataxia, slurred speech, hallucinations, and stupor.</li>\r\n<li>Absence of ethanol odour despite intoxication should raise suspicion of EG ingestion.</li>\r\n</ul>\r\n<p><strong>Metabolic &amp; Cardiopulmonary Phase (12-24 hr):</strong></p>\r\n<ul>\r\n<li>Severe metabolic acidosis, nausea, vomiting, hyperventilation, hypotension, tachycardia.</li>\r\n<li>May develop hypocalcemic tetany, seizures, pulmonary oedema, and ARDS.</li>\r\n</ul>\r\n<p><strong>Renal Phase (24-72 hr):</strong></p>\r\n<ul>\r\n<li>Oliguria and acute tubular necrosis leading to acute kidney injury.</li>\r\n<li>Calcium oxalate crystals in urine are diagnostic and prognostic; chronic kidney damage is possible without therapy<strong></strong></li>\r\n</ul>\r\n<p><strong>Management:</strong></p>\r\n<ul>\r\n<li>Fomepizole is first-line; ethanol is a backup if unavailable.</li>\r\n<li>Dialysis is life-saving in severe cases and essential when acidosis or renal compromise persists.</li>\r\n<li>Supportive measures, including vitamins and correction of metabolic abnormalities, may help reduce organ toxicity.</li>\r\n</ul>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">High salt intake</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Low fluid intake</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Compression garments</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Elevate the head end of BED 10cm to minimise supine hypertension.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is not a component of the initial treatment of orthostatic hypotension?</span></p>",
      "unique_key": "DT1196685",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196685,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Low fluid intake is not a component of the initial treatment of orthostatic hypotension.</p>\r\n<ul>\r\n<li>Encouraging low fluid intake would worsen hypovolemia and aggravate orthostatic intolerance.</li>\r\n<li>Adequate hydration is essential, and dehydration is a known trigger to avoid.<strong></strong></li>\r\n</ul>\r\n<p><strong>Initial treatment of orthostatic hypotension (OH) includes:</strong></p>\r\n<ul>\r\n<li>Patient education: Mechanisms and stresses of OH</li>\r\n<li>High salt diet (10-20 gm/day)<strong>(Option A)</strong></li>\r\n<li>Compression garments<strong>(Option C)</strong></li>\r\n<li>Correct anemia</li>\r\n<li>Raise the head end of the bed 10 cm to reduce supine hypertension<strong>(Option C)</strong></li>\r\n<li>Maintain postural stimuli</li>\r\n<li>Learn physical counter - Maneuvers</li>\r\n</ul>",
      "correct_choice_id": 102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">IV fluids and diuretics</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">IV phosphate</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">IV bisphosphonates</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Subcutaneous calcitonin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old male patient who is a known case of lung cancer presents to the physician with complaints of generalised weakness and serum calcium of 16.4mg/dl. What would be the next step in the management of the patient?</span></p>",
      "unique_key": "DT1196691",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196691,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This is hypercalcemia of malignancy, a common paraneoplastic syndrome in lung cancer, especially squamous cell carcinoma.</p>\r\n<ul>\r\n<li>It is often caused by the secretion of parathyroid hormone-related peptide (PTHrP).</li>\r\n<li>The patient presents with an acute hypercalcemic crisis, which can result in the development of systolic arrest of the heart.</li>\r\n<li>Therefore, it is imperative to decrease the serum calcium of the patient with the administration of normal saline and eventually a furosemide drip.<strong></strong></li>\r\n</ul>\r\n<p><strong>First-line, immediate treatment</strong>:</p>\r\n<ul>\r\n<li>Aggressive IV hydration with normal saline to correct volume depletion and enhance renal calcium excretion.</li>\r\n<li>Once adequately hydrated, loop diuretics (e.g., furosemide) may be added only if there's volume overload or to increase calcium excretion.<strong></strong></li>\r\n</ul>\r\n<p><strong>Next steps after stabilisation</strong>:</p>\r\n<ul>\r\n<li>IV bisphosphonates (e.g., zoledronic acid or pamidronate) to inhibit bone resorption take 2-4 days to take effect. <strong>(Option C)</strong></li>\r\n<li>Calcitonin may be used for rapid but short-term lowering of calcium while waiting for bisphosphonates to work. <strong>(Option D)</strong></li>\r\n</ul>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Inability to complete sentences in one breath</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Raised PCO2</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Peak expiratory flow rate (PEFR) <33%</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Need for mechanical ventilation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following features of an asthma attack is classified as 'life-threatening' in asthma?</span></p>",
      "unique_key": "DT1196695",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196695,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>A peak expiratory flow rate (PEFR) &lt;33% is considered a life-threatening situation of asthma.<strong></strong></p>\r\n<p><strong>The given table below tells the classification of acute asthma:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d19tx39t2q3u48.cloudfront.net/NEETPGMCQ/78401623-6208-4e04-a8f1-b49f3dcdb446.png\">",
      "correct_choice_id": 123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium-sparing diuretics should be avoided in patients with hypokalemic periodic paralysis.</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Rocuronium use should be avoided in patients with myasthenia gravis</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Patients with motor neurone disease typically require double the standard dose of suxamethonium to provide optimum intubating conditions.</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Local anaesthesia can exacerbate symptoms of multiple sclerosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">About a patient with a neuromuscular disorder on the critical care unit, which is true:</span></p>",
      "unique_key": "DT1196699",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196699,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Myasthenia gravis patients are highly sensitive to non-depolarising neuromuscular blockers like rocuronium, meaning they may experience prolonged paralysis even with small doses.</p>\r\n<ul>\r\n<li>This can complicate ventilation and recovery. If neuromuscular blockade is essential, careful titration and neuromuscular monitoring are critical.</li>\r\n<li>Myasthenia Gravis (MG) is an autoimmune disorder where antibodies target and reduce the number or function of postsynaptic nicotinic acetylcholine receptors (AChRs) at the neuromuscular junction. This leads to muscle weakness, particularly with repetitive use.<strong></strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong><strong></strong></p>\r\n<p><strong>Potassium-sparing diuretics should be avoided in patients with hypokalemic periodic paralysis (Option A): </strong>Potassium-sparing diuretics (like spironolactone or amiloride) can be beneficial in hypokalemic periodic paralysis because they help prevent potassium loss and reduce the risk of triggering an attack.<strong></strong></p>\r\n<p><strong>Rocuronium use should be avoided in patients with myasthenia gravis (Option B):</strong></p>\r\n<ul>\r\n<li>This is dangerous. Patients with motor neurone disease (e.g., ALS) often have upregulated extrajunctional acetylcholine receptors, which makes them prone to hyperkalemia with suxamethonium (succinylcholine).</li>\r\n<li>Suxamethonium is contraindicated in these patients due to the risk of life-threatening hyperkalemia.<strong></strong></li>\r\n</ul>\r\n<p><strong>Patients with motor neurone disease typically require double the standard dose of suxamethonium to provide optimum intubating conditions (Option C):</strong></p>\r\n<ul>\r\n<li>There is no strong evidence that local anaesthetics exacerbate MS. Regional and local anaesthesia are generally considered safe in MS.</li>\r\n<li>The concern is mainly theoretical, particularly with spinal (intrathecal) anaesthesia, and high concentrations of certain local anaesthetics, but it's not a firm contraindicati.on<strong></strong></li>\r\n</ul>\r\n<p><strong>Key takeaways:</strong><strong></strong></p>\r\n<p><strong>Some of the medications reported to cause exacerbations of myasthenia gravis (MG) include the following:</strong></p>\r\n<ul>\r\n<li>Antibiotics: macrolides, fluoroquinolones, aminoglycosides, tetracycline, and chloroquine.</li>\r\n<li>Antiarrhythmic agents beta -blockers, calcium channel blockers, quinidine, lignocaine, procainamide, and trimethaphan.</li>\r\n<li>Miscellaneous - diphenylhydantoin, lithium, chlorpromazine, muscle relaxants, levothyroxine, adrenocorticotropic hormone (ACTH), and, paradoxically, corticosteroids.</li>\r\n</ul>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Better prognosis in older patients</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Better prognosis in those with high alcohol consumption</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoglycaemia rarely happens within 12 hours of the onset of encephalopathy</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Lactic acidosis is a recognised complication</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old man is admitted following a serious attempt at paracetamol overdose. Despite efforts to treat him, he develops liver failure. Which of the following is most likely associated with the ensuing liver failure?</span></p>",
      "unique_key": "DT1196705",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196705,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Lactic acidosis is due to decreased hepatic lactate clearance, compounded by poor peripheral perfusion and increased lactate.</p>\r\n<ul>\r\n<li>Hepatic mitochondrial dysfunction leads to impaired oxidative phosphorylation.<br /> This results in increased anaerobic metabolism and lactate production.</li>\r\n<li>Combined with reduced hepatic clearance of lactate, this leads to lactic acidosis.<br /> It is especially common in fulminant hepatic failure and is often a poor prognostic marker.</li>\r\n<li>Use of intravenous N-acetylcysteine reduces morbidity and mortality in fulminant hepatic failure.</li>\r\n<li>Severe hypoglycemia affects 40% of patients with fulminant liver failure, which exacerbates encephalopathy.<strong></strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong><strong></strong></p>\r\n<p><strong>Better prognosis in older patients(Option A): </strong>Older age is generally associated with a <strong>worse prognosis</strong> in acute liver failure.<strong></strong></p>\r\n<p><strong>Better prognosis in those with high alcohol consumption(Option B):</strong> Chronic alcohol use <strong>worsens</strong> prognosis. It can exacerbate liver damage and deplete glutathione, making paracetamol toxicity <strong>more severe</strong>.</p>\r\n<p><strong>Hypoglycaemia rarely happens within 12 hours of the onset of encephalopathy(Option C): </strong>In acute liver failure, hypoglycaemia is common and may occur early, even before encephalopathy. The liver fails to maintain normal glucose homeostasis due to impaired gluconeogenesis and glycogenolysis.</p>",
      "correct_choice_id": 144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Suspected bacteremia is not a contraindication to LP.</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin should be stopped for at least 24 hours prior to LP.</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">LP can be attempted in patients with a suspected spinal epidural abscess.</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">It is recommended that LP is not performed in patients with platelet counts of &lt;100000/ul.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Regarding diagnostic lumbar puncture (LP), the true statement is:</span></p>",
      "unique_key": "DT1196713",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196713,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>A lumbar puncture is often essential in suspected bacteremia when meningitis is also suspected, to guide diagnosis and treatment.</p>\r\n<ul>\r\n<li>If meningitis is suspected, delaying LP because of bacteremia could delay diagnosis and appropriate therapy.</li>\r\n<li>Blood cultures should also be obtained, and empiric antibiotics started before LP if there's any delay.<strong></strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Aspirin should be stopped for at least 24 hours before LP (Option B):</strong></p>\r\n<ul>\r\n<li>Antiplatelet therapy with aspirin and non-steroidal anti-inflammatory agents has not been demonstrated to be associated with increased bleeding after LP.</li>\r\n<li>It is recommended to suspend therapy, when possible, before elective LP.</li>\r\n<li>The antiplatelet effect of aspirin will take around a week to wear off.<strong></strong></li>\r\n</ul>\r\n<p><strong>LP can be attempted in patients with a suspected spinal epidural abscess (Option C):</strong></p>\r\n<ul>\r\n<li>It is contraindicated in patients with a suspected spinal epidural abscess.</li>\r\n<li>It may introduce infection into the subarachnoid space or worsen spinal cord compression.MRI is the preferred diagnostic tool.<strong></strong></li>\r\n</ul>\r\n<p><strong>It is recommended that LP is not performed in patients with platelet counts of &lt;100000/ul (Option D):</strong></p>\r\n<ul>\r\n<li>Performing an LP is not recommended in patients with coagulation defects who are actively bleeding, have severe thrombocytopenia (e.g. platelet counts&lt;50000/ul, INR&gt;1.4, without correcting the underlying abnormalities)<strong></strong></li>\r\n</ul>\r\n<p><strong>Key takeaways:</strong><strong></strong></p>\r\n<p><strong>Prognostic models for traumatic brain injury (TBI) include:</strong></p>\r\n<ul>\r\n<li>Age, GCS, pupillary reaction, injury sustained within a low-middle income country, extracranial injury and CT findings.</li>\r\n<li>Serum glucose, temperature, hypercarbia, hypotension and hypoxia are recently included and dreaded secondary insults.</li>\r\n<li>The presence of sensory deficit plays no role.</li>\r\n</ul>",
      "correct_choice_id": 151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">It is a highly effective treatment for thrombotic thrombocytopenic purpura.</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">The most commonly used replacement fluid is 4.5% albumin in physiological saline.</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Therapeutic plasma exchange requires central venous access.</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Paraesthesia is a common complication.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Regarding plasma exchange, the false statement is:</span></p>",
      "unique_key": "DT1196723",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196723,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>While central access is frequently used, up to 67% of therapeutic plasma exchange procedures can be completed successfully with peripheral venous access.</p>\r\n<ul>\r\n<li>Therapeutic plasma exchange is a procedure in which large volumes of plasma are removed from the patient and replaced with some form of replacement fluid.</li>\r\n<li>The most commonly used replacement fluid is 4.5% human albumin in physiological saline, although the use of fresh frozen plasma is preferred in a limited number of disorders. <strong>(Option B ruled out)</strong></li>\r\n<li>Plasma exchange is most useful for autoimmune and immunoproliferative disease(ttp). <strong>(Option A ruled out)</strong></li>\r\n<li>Paraesthesia related to hypocalcaemia resulting from the use of citrate anticoagulant is a common complication. <strong>(Option D ruled out)</strong><strong></strong></li>\r\n</ul>\r\n<p><strong>Indications of plasma exchange:</strong></p>\r\n<ul>\r\n<li>Thrombotic thrombocytopenic purpura (TTP)</li>\r\n<li>Guillain-Barr&eacute; syndrome</li>\r\n<li>Myasthenia gravis (especially in myasthenic crisis)\\</li>\r\n<li>Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)</li>\r\n<li>Goodpasture's syndrome (anti-GBM disease)</li>\r\n<li>ANCA-associated vasculitis with pulmonary-renal syndrome</li>\r\n<li>Cryoglobulinemia with organ involvement</li>\r\n<li>Hyperviscosity syndrome (e.g., in Waldenstr&ouml;m's macroglobulinemia)</li>\r\n<li>Catastrophic antiphospholipid syndrome (CAPS)</li>\r\n<li>Fulminant hepatic failure (select cases, bridge to transplant)<strong></strong></li>\r\n</ul>\r\n<p><strong>Complications of Plasma exchange:</strong></p>\r\n<ul>\r\n<li>Hypocalcemia - from citrate anticoagulant &rarr; can cause tingling, paraesthesia, cramps.</li>\r\n<li>Allergic reactions - especially when FFP is used.</li>\r\n<li>Infection - due to central line use.</li>\r\n<li>Hypotension, bleeding, or clotting abnormalities.</li>\r\n<li>Volume shifts and electrolyte disturbances.</li>\r\n</ul>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelet transfusion is recommended to maintain a platelet count of 10 x 10^9/L.</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">The principal abnormality occurs due to the production of an abnormal WF cleaving protein.</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">The diagnosis includes proven or suspected arterial or venous thrombosis.</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Administration of solvent/detergent-treated fresh frozen plasma is a useful treatment option</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">False regard to thrombotic thrombocytopenia purpura (TTP) is:False regarding thrombotic thrombocytopenia purpura (TTP) is:</span></p>",
      "unique_key": "DT1196727",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196727,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Platelet transfusions are essentially contraindicated in the absence of serious bleeding.<strong></strong></p>\r\n<p><strong>TTP:</strong></p>\r\n<ul>\r\n<li>Thrombotic thrombocytopenia purpura (TTP) is a rare thrombotic microangiopathy, occurring due to a deficiency of a specific von Willebrand factor cleaving protein known as ADAMTS13. <strong>(Option B ruled out)</strong><strong></strong></li>\r\n</ul>\r\n<p><strong>Deficiency leads to:</strong></p>\r\n<ul>\r\n<li>Accumulation of large vWF multimers</li>\r\n<li>Spontaneous platelet aggregation</li>\r\n<li>Formation of microthrombi in small vessels.<strong></strong></li>\r\n</ul>\r\n<p><strong>It is characterised by:</strong></p>\r\n<ul>\r\n<li>Thrombocytopenia</li>\r\n<li>Microangiopathic hemolytic anaemia (MAHA)</li>\r\n<li>Organ dysfunction, particularly neurological and renal.<strong></strong></li>\r\n</ul>\r\n<p><strong>Diagnosis:</strong></p>\r\n<ul>\r\n<li>The diagnostic pentad includes acute kidney injury, altered mental state, low platelets, fever and microangiopathic haemolytic anaemia. <strong>(Option C ruled out)</strong></li>\r\n<li>Not all features are necessary to make the diagnosis.<strong></strong></li>\r\n</ul>\r\n<p><strong>Treatment:</strong></p>\r\n<ul>\r\n<li>Treatment options include plasmapheresis as first line, fresh frozen plasma administration, steroids, rituximab and aspirin. <strong>(Option D ruled out)</strong></li>\r\n</ul>",
      "correct_choice_id": 171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">High-dose intravenous steroid therapy is a reasonable initial treatment option.</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">TLS is most commonly associated with squamous cell and neuroendocrine tumours.</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Clinical TLS can be diagnosed in a patient with seizures and the presence of appropriate laboratory findings.</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">An increase in serum calcium and potassium levels by >25% is the hallmark feature of laboratory TLS.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">True concerning the tumour lysis syndrome (TLS):</span></p>",
      "unique_key": "DT1196734",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196734,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Clinical TLS is diagnosed using the Cairo-Bishop criteria, which include:</strong></p>\r\n<p><strong>Laboratory TLS</strong>: Elevated uric acid, potassium, phosphate, and low calcium (any two lab abnormalities).</p>\r\n<p><strong>Clinical TLS</strong>: Laboratory TLS plus one or more clinical complications such as:</p>\r\n<ul>\r\n<li>Renal insufficiency</li>\r\n<li>Seizures</li>\r\n<li>Cardiac arrhythmias</li>\r\n<li>Sudden death<strong></strong></li>\r\n</ul>\r\n<p><strong>Tumour lysis syndrome:</strong></p>\r\n<ul>\r\n<li>Tumour lysis syndrome (TLS) is a potentially life-threatening complication of massive cellular lysis in cancer, often encountered in bulky, rapidly progressive or chemo-sensitive tumours.</li>\r\n<li>It is most commonly seen in haematological malignancy. <strong>(Option B ruled out)</strong></li>\r\n<li>Hypocalcaemia is a hallmark feature due to precipitation of ionised calcium with phosphate, which is released in large quantities in tumour lysis. <strong>(Option D ruled out)</strong></li>\r\n<li>Other laboratory features of TLS include: an increase in serum uric acid by &gt;25% from baseline; an increase in serum potassium by &gt;25% from baseline; an increase in serum phosphate by &gt;25% from baseline.</li>\r\n<li>Intravenous hydration and rasburicase are first-line treatments and prophylaxis agents in high-risk groups. <strong>(Option A ruled out)</strong></li>\r\n</ul>",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumonia</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural effusion</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Near drowning</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A and B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a cause of type 2 respiratory failure?</span></p>",
      "unique_key": "DT1196737",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196737,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Any pathological process that affects the gas exchange at the level of alveoli will cause type 1 respiratory failure.</strong></p>\r\n<p><strong>These include causes of acute respiratory distress syndrome, like:</strong></p>\r\n<ul>\r\n<li>Pneumonia<strong>(Option A ruled out)</strong></li>\r\n<li>Sepsis</li>\r\n<li>Multiple blood transfusions</li>\r\n<li>Near drowning<strong>(Option C ruled out)</strong></li>\r\n<li>Pancreatitis</li>\r\n<li>Aspiration pneumonitis<strong></strong></li>\r\n</ul>\r\n<p><strong>Type 2 respiratory failure is caused by any process that impairs the entry of air into the lungs. </strong></p>\r\n<p><strong>This includes:</strong></p>\r\n<ul>\r\n<li><strong>Central causes:</strong>\r\n<ul>\r\n<li>Cerebrovascular stroke causing brain stem injury</li>\r\n<li>drug overdose</li>\r\n<li>sleep-disordered breathing</li>\r\n<li>severe hypothyroidism.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Peripheral causes</strong>\r\n<ul>\r\n<li>Nerve: GBS, phrenic nerve injury</li>\r\n<li>Neuromuscular junction: myasthenic crisis</li>\r\n<li>Muscle: muscle dystrophies</li>\r\n<li>Pleural effusion<strong></strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Type 3 respiratory failure:</strong></p>\r\n<ul>\r\n<li>Type 3 respiratory failure results from lung atelectasis. Because atelectasis occurs so commonly in the perioperative period, this form is also called perioperative respiratory failure.</li>\r\n<li>After general anaesthesia, decreases in functional residual capacity lead to collapse of dependent lung units.</li>\r\n<li>Such atelectasis can be treated by frequent changes in position, chest physiotherapy, upright positioning, and control of incisional and/or abdominal pain.</li>\r\n<li>Noninvasive positive-pressure ventilation may also be used to reverse regional atelectasis.<strong></strong></li>\r\n</ul>\r\n<p><strong>Criteria for Acute respiratory distress syndrome:</strong></p>\r\n<p>Left atrial pressure should be normal to classify the patient as ARDS. Acute respiratory distress syndrome (ARDS) is a clinical syndrome of severe dyspnea of rapid onset, hypoxemia, and diffuse pulmonary infiltrates leading to respiratory failure.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250920ed3dfb3a-da3a-4a79-ae27-dc2d3b2cf271.png\">",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Early neuromuscular blockade</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Low tidal volume ventilation</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocorticoids</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Recruitment manoeuvre</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following strategies is most beneficial in the initial management of acute respiratory syndrome?</span></p>",
      "unique_key": "DT1196742",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196742,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Ventilator-induced lung injury can arise from at least two principal mechanisms:</strong></p>\r\n<ul>\r\n<li>\"<strong>Volutrauma\"</strong> from repeated alveolar overdistention from excess tidal volume (that might also coincide with increased alveolar pressures, or \"barotrauma\") and &amp;\"<strong>atelectrauma\"</strong> from recurrent alveolar collapse.</li>\r\n<li>A large-scale, randomised controlled trial showed that mortality was significantly lower (31%) in patients with low tidal volume ventilation compared to those treated with conventional tidal volume.<strong></strong></li>\r\n</ul>\r\n<p><strong>Other strategies are explained in the given table:</strong></p><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d19tx39t2q3u48.cloudfront.net/NEETPGMCQ/5ef3cacc-4f4f-4600-98d3-0ed58bc02101.png\"><p>LOR: Level Of Recommendation</p>\r\n<p>ECMO: ExtraCorporeal Membrane Oxygenation</p>",
      "correct_choice_id": 202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage I: T1N1M0</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage III: T1N1M0</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage II: T2N1M0</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage IVA: T1N2cM0</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54-year-old male presents with a complaint of a non-healing ulcer over the left lateral border of the tongue. On examination, an ulcero-proliferative growth of 1.5 x 1 cm is seen involving the left lateral border of the tongue; the base of the tongue is free. Also, a single 4 x 3 cms right level 2 lymph node is seen. What is the correct TNM staging according to the AJCC 8th edition?</span></p>",
      "unique_key": "DT1197987",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197987,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The above given presentation belongs to stage IVA of TNM staging.</p>\r\n<p><strong>The TNM staging of the tongue carcinoma is given below:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024040417192c97-6536-42ce-b0c5-357a34119064.jpg\">\r\n<p><strong>Key Takeaways:</strong></p>\r\n<p><strong>HPV associated head and neck tumours are seen in:</strong></p>\r\n<ul>\r\n<li>Younger age</li>\r\n<li>Multiple sexual partners</li>\r\n<li>Oral sex</li>\r\n</ul>\r\n<p>It has a Better prognosis.</p>",
      "correct_choice_id": 214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenocarcinoma</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell cancer</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-small cell lung cancer</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Small cell lung cancer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which lung cancer stains positive for CD56, NCAM, synaptophysin and chromogranin?</span></p>",
      "unique_key": "DT1197991",
      "question_audio": null,
      "question_video": null,
      "map_id": 1197991,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>CD 56, NCAM, synaptophysin and Chromogranin are neuroendocrine markers and will be positive in small cell carcinoma lung.</li>\r\n<li>Nap-A and TTF 1 are other immunohistochemical markers that can be used in the diagnosis of lung cancer.</li>\r\n<li>Cytokeratins 7 and 20 used in combination can help narrow the differential diagnosis; nonsquamous NSCLC, SCLC, and mesothelioma may stain positive for CK7 and negative for CK20, whereas squamous cell lung cancer often will be both CK7 and CK20 negative.<strong></strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Adenocarcinoma(Option A):</strong> Nap-A positive, TTF-1 positive, not positive for neuroendocrine markers.</p>\r\n<p><strong>Squamous cell carcinoma(Option B):</strong> Nap-A negative, TTF-1 negative, not positive for the neuroendocrine markers.</p>\r\n<p><strong>Non-small cell lung cancer(Option C):</strong> This is an umbrella term that includes adenocarcinoma and squamous cell carcinoma; most NSCLCs do not express neuroendocrine markers.<strong></strong></p>\r\n<p><strong>Key Takeaways:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509207087fa7d-0690-4e0d-891b-a59376ec5ad3.PNG\">",
      "correct_choice_id": 224,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">EGFR mutation</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">EGFR rearrangement</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">KRAS mutation</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">ALK rearrangement</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The most frequently seen driver mutation in Non-small cell lung cancer is</span></p>",
      "unique_key": "DT1198000",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198000,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The most frequently seen driver mutation in Non-small cell lung cancer is the <strong>EGFR mutation.</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024040433564761-6746-4356-a38b-c824f7278776.jpg\">\r\n<p><strong>Driver mutations seen in squamous cell cancer of the lung:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024040433564761-6746-4356-a38b-c824f7278776.jpg\"><p><strong>Driver mutation seen in adenocarcinoma of the lung:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024040433564761-6746-4356-a38b-c824f7278776.jpg\"><p><strong>Small cell lung carcinoma:</strong></p>\r\n<ul>\r\n<li>Small cell lung cancer is associated with a <strong>TP53 mutation RB1 mutation.</strong></li>\r\n</ul>",
      "correct_choice_id": 231,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Detecting the cancer earlier without an effect on survival</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Indolent cancers are detected on screening and may not affect survival, whereas aggressive cancers are likely to cause symptoms earlier in patients and are less likely to be detected</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Diagnosing cancers so slow growing that they are unlikely to cause the death of the patient</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Length time bias in cancer screening is defined as</span></p>",
      "unique_key": "DT1198008",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198008,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>With any screening procedure, it is important to consider the possible influence of:</p>\r\n<ul>\r\n<li>Lead-time bias: Detecting the cancer earlier without an effect on survival.</li>\r\n<li>Length-time bias: Indolent cancers are detected on screening and may not affect survival, whereas aggressive cancers are likely to cause symptoms earlier in patients and are less likely to be detected.</li>\r\n<li>Overdiagnosis: Diagnosing cancers so slow-growing that they are unlikely to cause the death of the patient.</li>\r\n</ul>",
      "correct_choice_id": 242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Paraneoplastic syndromes associated with lung cancer is/are<br>1. Ectopic ACTH<br>2. SIADH<br>3. Lambert-Eaton Syndrome<br>4. Trousseau syndrome</span></p>",
      "unique_key": "DT1198012",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198012,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Paraneoplastic syndromes associated with Lung Cancer:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403304eed0307-a3e4-4354-b929-ee203ab2e5cb.jpg\"><p><strong>Trousseau syndrome:</strong></p>\r\n<ul>\r\n<li>Trousseau syndrome refers to migratory superficial thrombophlebitis.</li>\r\n<li>It is a paraneoplastic manifestation of pancreatic adenocarcinoma<strong>(Option 4).</strong></li>\r\n</ul>",
      "correct_choice_id": 251,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage IIIA</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage IIIB</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage IIIC</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage IVA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with Left lung upper lobe NSCLC (5 x 7cms) with right level 2 lymphadenopathy. What would be the stage of his disease?</span></p>",
      "unique_key": "DT1198014",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198014,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The above given presentation belongs to<strong> Stage IIIC.</strong></p>\r\n<p><strong>Staging of the LC:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403303db8579c-f895-4dcb-a79e-90f8fefb09f0.jpg\"><p><strong>TNM staging:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025092019404553-dd76-49ec-a1d1-940c81546ed3.png\">",
      "correct_choice_id": 263,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumonectomy followed by adjuvant chemo-radiation</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Lobectomy followed by adjuvant chemo-radiation</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Concurrent chemo-radiation</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Concurrent chemoradiation followed by Durvalumab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The treatment of choice for stage IIIC NSCLC is</span></p>",
      "unique_key": "DT1198025",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198025,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The treatment of choice for stage IIIC NSCLC is <strong>Concurrent chemoradiation followed by Durvalumab.</strong></p>\r\n<p><strong>Management of stage III NSCLC:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240330f0b4830f-8b63-4cb9-8769-c6081dd7406f.jpg\">",
      "correct_choice_id": 274,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}